Our research is used by government agencies, foundations, and others to advance better health policies and programs.
Who benefits from manufacturer drug rebates? A new report from the Altarum Center for Value in Health Care examines the impact of behind-the-scenes rebates on both health plans and consumers.
In March 2018, the Health Care Price Index rose by 2.2% compared to the previous year, fractionally higher than in February, and the highest rate since January 2012.
Funded by the Robert Wood Johnson Foundation, this report provides a summary of key trends in Q4 2017 in health care spending, prices, utilization, and employment.
Altarum's latest Health Sector Economic Indicators provide a second look at spending for the entire 2017 calendar year and suggest that national health spending grew by 4.6% from its 2016 level.
National health spending rose 4.7% in 2017, slightly above GDP, but keeping its share of GDP at 18%, according to Altarum’s latest Health Sector Economic Indicators Briefs.
U.S. health sector spending continues to grow at a more sustainable rate, driven in part by a slowdown in hiring, hospital spending, and price growth in hospitals, physician and clinical services, and prescription drugs.
Funded by the Robert Wood Johnson Foundation, this report provides a summary of key trends in Q3 2017 in health care spending, prices, utilization, and employment.
New data released by the Centers for Medicare & Medicaid Services (CMS) show slower health sector growth in 2016.